Here we confirmed that COVID-19 mRNA vaccines generate robust S-specific CD4+ and CD8+ T-cell responses that can be detected up to four-months post-second dose23, and that the CD4+ T-cell response is larger in magnitude than the CD8+ T-cell response. This evidence concerns the gene CD8A and COVID-19.